Cargando…
Perioperative cardioprotection
Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharma...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590787/ https://www.ncbi.nlm.nih.gov/pubmed/23513179 http://dx.doi.org/10.12703/P5-7 |
_version_ | 1782261931828051968 |
---|---|
author | Leung, May KM Irwin, Michael G |
author_facet | Leung, May KM Irwin, Michael G |
author_sort | Leung, May KM |
collection | PubMed |
description | Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients. |
format | Online Article Text |
id | pubmed-3590787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35907872013-03-19 Perioperative cardioprotection Leung, May KM Irwin, Michael G F1000Prime Rep Review Article Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients. Faculty of 1000 Ltd 2013-03-04 /pmc/articles/PMC3590787/ /pubmed/23513179 http://dx.doi.org/10.12703/P5-7 Text en © 2013 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Leung, May KM Irwin, Michael G Perioperative cardioprotection |
title | Perioperative cardioprotection |
title_full | Perioperative cardioprotection |
title_fullStr | Perioperative cardioprotection |
title_full_unstemmed | Perioperative cardioprotection |
title_short | Perioperative cardioprotection |
title_sort | perioperative cardioprotection |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590787/ https://www.ncbi.nlm.nih.gov/pubmed/23513179 http://dx.doi.org/10.12703/P5-7 |
work_keys_str_mv | AT leungmaykm perioperativecardioprotection AT irwinmichaelg perioperativecardioprotection |